|
Volumn 19, Issue 10, 2013, Pages 1193-
|
First IL-6–blocking drug nears approval for rare blood disorder
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INTERLEUKIN 6;
MONOCLONAL ANTIBODY;
SILTUXIMAB;
ANTAGONISTS AND INHIBITORS;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
GIANT LYMPH NODE HYPERPLASIA;
HUMAN;
LEGISLATION AND JURISPRUDENCE;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
GIANT LYMPH NODE HYPERPLASIA;
HUMANS;
INTERLEUKIN-6;
|
EID: 84900428111
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm1013-1193 Document Type: Note |
Times cited : (18)
|
References (0)
|